These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 33485325)

  • 1. The negative charge of the 343 site is essential for maintaining physiological functions of CXCR4.
    Wang L; Xiong Q; Li P; Chen G; Tariq N; Wu C
    BMC Mol Cell Biol; 2021 Jan; 22(1):8. PubMed ID: 33485325
    [TBL] [Abstract][Full Text] [Related]  

  • 2. WHIM syndrome caused by a single amino acid substitution in the carboxy-tail of chemokine receptor CXCR4.
    Liu Q; Chen H; Ojode T; Gao X; Anaya-O'Brien S; Turner NA; Ulrick J; DeCastro R; Kelly C; Cardones AR; Gold SH; Hwang EI; Wechsler DS; Malech HL; Murphy PM; McDermott DH
    Blood; 2012 Jul; 120(1):181-9. PubMed ID: 22596258
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhanced function with decreased internalization of carboxy-terminus truncated CXCR4 responsible for WHIM syndrome.
    Kawai T; Choi U; Whiting-Theobald NL; Linton GF; Brenner S; Sechler JM; Murphy PM; Malech HL
    Exp Hematol; 2005 Apr; 33(4):460-8. PubMed ID: 15781337
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hierarchical organization of multi-site phosphorylation at the CXCR4 C terminus.
    Mueller W; Schütz D; Nagel F; Schulz S; Stumm R
    PLoS One; 2013; 8(5):e64975. PubMed ID: 23734232
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Filamin A interaction with the CXCR4 third intracellular loop regulates endocytosis and signaling of WT and WHIM-like receptors.
    Gómez-Moutón C; Fischer T; Peregil RM; Jiménez-Baranda S; Stossel TP; Nakamura F; Mañes S
    Blood; 2015 Feb; 125(7):1116-25. PubMed ID: 25355818
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CXCR4 dimerization and beta-arrestin-mediated signaling account for the enhanced chemotaxis to CXCL12 in WHIM syndrome.
    Lagane B; Chow KY; Balabanian K; Levoye A; Harriague J; Planchenault T; Baleux F; Gunera-Saad N; Arenzana-Seisdedos F; Bachelerie F
    Blood; 2008 Jul; 112(1):34-44. PubMed ID: 18436740
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The complex nature of CXCR4 mutations in WHIM syndrome.
    Rodríguez-Frade JM; González-Granado LI; Santiago CA; Mellado M
    Front Immunol; 2024; 15():1406532. PubMed ID: 39035006
    [TBL] [Abstract][Full Text] [Related]  

  • 8. WHIM syndrome myelokathexis reproduced in the NOD/SCID mouse xenotransplant model engrafted with healthy human stem cells transduced with C-terminus-truncated CXCR4.
    Kawai T; Choi U; Cardwell L; DeRavin SS; Naumann N; Whiting-Theobald NL; Linton GF; Moon J; Murphy PM; Malech HL
    Blood; 2007 Jan; 109(1):78-84. PubMed ID: 16946301
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of a new WHIM syndrome mutant reveals mechanistic differences in regulation of the chemokine receptor CXCR4.
    Luo J; De Pascali F; Richmond GW; Khojah AM; Benovic JL
    J Biol Chem; 2022 Feb; 298(2):101551. PubMed ID: 34973340
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CXCR4-Specific Nanobodies as Potential Therapeutics for WHIM syndrome.
    de Wit RH; Heukers R; Brink HJ; Arsova A; Maussang D; Cutolo P; Strubbe B; Vischer HF; Bachelerie F; Smit MJ
    J Pharmacol Exp Ther; 2017 Oct; 363(1):35-44. PubMed ID: 28768817
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impaired recruitment of Grk6 and beta-Arrestin 2 causes delayed internalization and desensitization of a WHIM syndrome-associated CXCR4 mutant receptor.
    McCormick PJ; Segarra M; Gasperini P; Gulino AV; Tosato G
    PLoS One; 2009 Dec; 4(12):e8102. PubMed ID: 19956569
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reduced G protein signaling despite impaired internalization and β-arrestin recruitment in patients carrying a CXCR4Leu317fsX3 mutation causing WHIM syndrome.
    Kumar R; Milanesi S; Szpakowska M; Dotta L; Di Silvestre D; Trotta AM; Bello AM; Giacomelli M; Benedito M; Azevedo J; Pereira A; Cortesao E; Vacchini A; Castagna A; Pinelli M; Moratto D; Bonecchi R; Locati M; Scala S; Chevigné A; Borroni EM; Badolato R
    JCI Insight; 2023 Mar; 8(5):. PubMed ID: 36883568
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CXCL12/CXCR4-axis dysfunctions: Markers of the rare immunodeficiency disorder WHIM syndrome.
    Bachelerie F
    Dis Markers; 2010; 29(3-4):189-98. PubMed ID: 21178277
    [TBL] [Abstract][Full Text] [Related]  

  • 14. WHIM Syndrome Caused by Waldenström's Macroglobulinemia-Associated Mutation CXCR4 (L329fs).
    Liu Q; Pan C; Lopez L; Gao J; Velez D; Anaya-O'Brien S; Ulrick J; Littel P; Corns JS; Ellenburg DT; Malech HL; Murphy PM; McDermott DH
    J Clin Immunol; 2016 May; 36(4):397-405. PubMed ID: 27059040
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mesenchymal Stem/Stromal Cells Overexpressing CXCR4
    Bidkhori HR; Bahrami AR; Farshchian M; Heirani-Tabasi A; Mirahmadi M; Hasanzadeh H; Ahmadiankia N; Faridhosseini R; Dastpak M; Shabgah AG; Matin MM
    Cell Transplant; 2021; 30():9636897211054498. PubMed ID: 34807749
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aberrant CXCR4 Signaling at Crossroad of WHIM Syndrome and Waldenstrom's Macroglobulinemia.
    Milanesi S; Locati M; Borroni EM
    Int J Mol Sci; 2020 Aug; 21(16):. PubMed ID: 32784523
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutations in the chemokine receptor gene CXCR4 are associated with WHIM syndrome, a combined immunodeficiency disease.
    Hernandez PA; Gorlin RJ; Lukens JN; Taniuchi S; Bohinjec J; Francois F; Klotman ME; Diaz GA
    Nat Genet; 2003 May; 34(1):70-4. PubMed ID: 12692554
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expanding CXCR4 variant landscape in WHIM syndrome: integrating clinical and functional data for variant interpretation.
    Zmajkovicova K; Nykamp K; Blair G; Yilmaz M; Walter JE
    Front Immunol; 2024; 15():1411141. PubMed ID: 39040098
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Live imaging of neutrophil motility in a zebrafish model of WHIM syndrome.
    Walters KB; Green JM; Surfus JC; Yoo SK; Huttenlocher A
    Blood; 2010 Oct; 116(15):2803-11. PubMed ID: 20592249
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Altered CXCR4 dynamics at the cell membrane impairs directed cell migration in WHIM syndrome patients.
    García-Cuesta EM; Rodríguez-Frade JM; Gardeta SR; D'Agostino G; Martínez P; Soler Palacios B; Cascio G; Wolf T; Mateos N; Ayala-Bueno R; Santiago CA; Lucas P; Llorente L; Allende LM; González-Granado LI; Martín-Cófreces N; Roda-Navarro P; Sallusto F; Sánchez-Madrid F; García-Parajo MF; Martínez-Muñoz L; Mellado M
    Proc Natl Acad Sci U S A; 2022 May; 119(21):e2119483119. PubMed ID: 35588454
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.